文献速递儿童青少年精神心境障碍

母亲精神疾病与SSRI治疗及子代神经发育障碍

Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders.
PubMed 文献 · Biol Psychiatry · 2021-04-14

基于美国多中心病例对照研究(ASD 1367例、DDs 1750例、对照1671例),母亲孕期精神疾病与子代ASD和DDs风险增加相关;在患有精神疾病的母亲中,孕期使用SSRI与子代ASD无显著关联。

要点

  • 母亲孕期精神疾病与子代ASD风险升高相关(aOR 1.81,95%CI 1.44-2.27)。
  • 患有精神疾病的母亲中,孕期SSRI使用与子代ASD无显著关联(aOR 1.14,95%CI 0.80-1.62)。
  • DDs结果与ASD呈现相似关联模式。

核心结论

  • 母亲孕期精神疾病而非SSRI使用与子代神经发育障碍风险增加相关。

研究设计与样本

  • 研究采用美国多中心病例对照设计(Study to Explore Early Development),纳入2003至2011年出生儿童,最终分组为ASD 1367例、DDs 1750例和一般人群对照1671例。
  • 母亲精神疾病和孕期SSRI使用通过自我报告与医疗记录确定,采用逻辑回归分析关联。

主要发现

  • 母亲孕期精神疾病和SSRI使用在ASD或DDs儿童母亲中比一般人群对照更常见。
  • 患有精神疾病但未使用SSRI的母亲子代ASD风险aOR为1.81(95%CI 1.44-2.27),使用SSRI的母亲aOR为2.05(95%CI 1.50-2.80)。
  • 在患有精神疾病的母亲中,SSRI使用与子代ASD无显著关联(aOR 1.14,95%CI 0.80-1.62)。
  • DDs的主要发现与ASD呈现相似关联模式。

临床怎么用

  • 临床评估孕期SSRI使用时,应综合考虑母亲精神疾病本身对子代神经发育风险的影响。
  • 对于患有精神疾病的孕妇,不应仅因子代神经发育风险而避免必要的SSRI治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aims to clarify relationships of maternal psychiatric conditions and selective serotonin reuptake inhibitor (SSRI) use during preconception and pregnancy with risk of neurodevelopmental disorders in offspring. METHODS: We used data from the Study to Explore Early Development, a multisite case-control study conducted in the United States among children born between 2003 and 2011. Final study group classifications of autism spectrum disorder (ASD) (n = 1367), developmental delays or disorders (DDs) (n = 1750), and general population controls (n = 1671) were determined by an in-person standardized developmental assessment. Maternal psychiatric conditions and SSRI use during pregnancy were ascertained from both self-report and medical records. We used logistic regression to evaluate associations of ASD and DDs (vs. population controls) with maternal psychiatric conditions and SSRI treatment in pregnancy. To reduce confounding by indication, we also examined SSRI associations in analyses restricted to mothers with psychiatric conditions during pregnancy. RESULTS: Psychiatric conditions and SSRI use during pregnancy were significantly more common among mothers of children with either ASD or DDs than among population controls. Odds of ASD were similarly elevated among mothers with psychiatric conditions who did not use SSRIs during pregnancy (adjusted odds ratio 1.81, 95% confidence interval 1.44-2.27) as in mothers who did use SSRIs (adjusted odds ratio 2.05, 95% confidence interval 1.50-2.80). Among mothers with psychiatric conditions, SSRI use was not significantly associated with ASD in offspring (adjusted odds ratio 1.14, 95% confidence interval 0.80-1.62). Primary findings for DDs exhibited similar relationships to those observed with ASD. CONCLUSIONS: Maternal psychiatric conditions but not use of SSRIs during pregnancy were associated with increased risk of neurodevelopmental disorders in offspring.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Ames JL, Ladd-Acosta C, Fallin MD, et al. Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders. Biol Psychiatry. 2021. PMID: 34116791. doi:10.1016/j.biopsych.2021.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。